More proof ObamaCare is working

The uninsured rate fell to 15.6 percent in the first quarter of the year, according to new Gallup data released Monday — the lowest it's been since 2008. And the rate has been falling since late last year, signaling that ObamaCare is indeed having its intended effect of extending insurance to more and more people. (The scale of the y-axis overstates the slope of the trend line, but you get the idea.)
Moreover, the rate fell precipitously in March, dropping from 15.8 percent at the month's outset to 14.7 percent come April. Such a steep drop is most likely an indication that many people raced to get insured right before ObamaCare's end-of-month enrollment deadline. And indeed, the administration reported that signups spiked in the month's closing days, pushing the total enrollments to 7.1 million.
Now, the drop alone doesn't mark the law as an unfettered success. It will be some time before the insurance marketplace adjusts to the increased customer pool, and enrollments are projected to rise ever higher over the coming years. But on a base level, the law is at least accomplishing its goal of insuring the uninsured, and the trend line looks favorable to its continued success.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jon Terbush is an associate editor at TheWeek.com covering politics, sports, and other things he finds interesting. He has previously written for Talking Points Memo, Raw Story, and Business Insider.
-
Gaza is running out of cash
Under The Radar Palestinians pay the price as black market springs up around banknotes and coins
By Elizabeth Carr-Ellis, The Week UK Published
-
Law firms: Caving to White House pressure
Feature Trump targets major law firms tied to his past investigations
By The Week US Published
-
Venezuelan deportees: Locked up for tattoos?
Feature A former pro soccer player was deported after U.S. authorities claimed his tattoo proved he belonged to a Venezuelan gang
By The Week US Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published